Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction “R3” Trial): protocol and study design

Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction “R3” Trial): protocol and study design

Abstract Background Individuals with two copies of the apolipoprotein-1 (APOL1) gene risk variants are at high risk (HR) for non-diabetic kidney disease. The presence of these risk variants is highest in West Africa, specifically in Nigeria. However, there is limited availability of dialysis and kid...

Full description

Bibliographic Details
Main Authors: Muktar H. Aliyu, Usman J. Wudil, Donna J. Ingles, Bryan E. Shepherd, Wu Gong, Baba M. Musa, Hamza Muhammad, Mahmoud U. Sani, Aliyu Abdu, Aisha M. Nalado, Akinfenwa Atanda, Aima A. Ahonkhai, Talat A. Ikizler, Cheryl A. Winkler, Jeffrey B. Kopp, Paul L. Kimmel, C. William Wester
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Trials
Subjects:
APOL1
Microalbuminuria
Kidney disease
Lisinopril
HIV
Nigeria
Online Access:http://link.springer.com/article/10.1186/s13063-019-3436-y

Internet

http://link.springer.com/article/10.1186/s13063-019-3436-y

Similar Items